The Role of Clopidogrel in 2020: A Reappraisal
Antiplatelet therapy is the mainstay of treatment and secondary prevention of cardiovascular disease (CVD), including acute coronary syndrome (ACS), transient ischemic attack (TIA) or minor stroke, and peripheral artery disease (PAD). The P2Y12 inhibitors, of which clopidogrel was the first, play an...
Saved in:
Main Authors: | Giuseppe Patti, Giuseppe Micieli, Claudio Cimminiello, Leonardo Bolognese |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Cardiovascular Therapeutics |
Online Access: | http://dx.doi.org/10.1155/2020/8703627 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Personalization of Clopidogrel Antiplatelet Therapy: The Role of Integrative Pharmacogenetics and Pharmacometabolomics
by: Arwa M. Amin, et al.
Published: (2017-01-01) -
A Role for RNA Viruses in the Pathogenesis of Burkitt's Lymphoma: The Need for Reappraisal
by: Corry van den Bosch
Published: (2012-01-01) -
Reappraisal and neotypification of Phyllachora feijoae
by: L.C. Costa, et al.
Published: (2012-06-01) -
Natal Teeth: A Case Report and Reappraisal
by: Ghadah A. Malki, et al.
Published: (2015-01-01) -
Cell Therapy for Refractory Angina: A Reappraisal
by: Beatrice Bassetti, et al.
Published: (2017-01-01)